Audio Summary: In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system? episode artwork

EPISODE · Aug 23, 2023 · 2 MIN

Audio Summary: In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

from RCVS Knowledge - Evidence-based Veterinary Medicine · host RCVS Knowledge

In this Audio Summary, Bonnie looks at whether lokivetmab is more effective than oclacitinib in reducing the Canine Atopic Dermatitis Lesion Index score (or some other recognised scoring system), in dogs with atopic skin disease. Read the full Knowledge Summary here.  Audio Summaries are a free resource that enable vets and vet nurses to more quickly and more easily access and digest relevant and up-to-date evidence! A time-saving way to make better and faster evidence-based decisions.

Episode metadata supplied by the publisher feed · Published Aug 23, 2023

Embed this episode

Ready to play

Audio Summary: In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

0:00 2:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RCVS Knowledge - Evidence-based Veterinary Medicine?

This episode is 2 minutes long.

When was this RCVS Knowledge - Evidence-based Veterinary Medicine episode published?

This episode was published on August 23, 2023.

Can I download this RCVS Knowledge - Evidence-based Veterinary Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!